1 Mortality |
3 |
10828 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.10 [0.98, 1.24] |
2 Total stroke |
2 |
9951 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.30 [1.11, 1.53] |
3 Total coronary heart disease |
2 |
9951 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.76, 1.06] |
4 Cardiovascular death |
3 |
10828 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.09 [0.92, 1.29] |
5 Total cardiovascular disease |
3 |
10828 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.72, 1.38] |
5.1 Angiotensin‐converting enzyme inhibitors |
2 |
1635 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.63, 1.04] |
5.2 Angiotensin receptor blockers |
1 |
9193 |
Risk Ratio (M‐H, Random, 95% CI) |
1.16 [1.04, 1.30] |
6 Withdrawal due to adverse effects |
2 |
9951 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.41 [1.29, 1.54] |